Further studies indicated apoptotic activity as revealed by the morphological changes in melanoma cells and supported by Western blot results that showed the downregulation of the anti-apoptotic Bcl-2 expression combined with the upregulation of the pro-apoptotic Bax. This evidence concerns the gene BCL2 and melanoma.